Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats

Brain Research

Volumn 1058, Issue 1-2, 2005, Pages 91-100

  Bruijnzeel, Adrie W ^a,b   Markou, Athina ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

D1 receptor; D2 receptor; Dopamine; Intracranial self stimulation; Nicotine; Rat

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ETICLOPRIDE; NICOTINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; MEASUREMENT; NONHUMAN; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REWARD; VENTRAL TEGMENTUM;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; HYPOTHALAMUS, POSTERIOR; MALE; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REWARD; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; VENTRAL TEGMENTAL AREA;

EID: 26244438664     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.07.056     Document Type: Article

References (70)

1. O. Aizman, H. Brismar, P. Uhlen, E. Zettergren, A.I. Levey, H. Forssberg, P. Greengard, and A. Aperia Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons Nat. Neurosci. 3 2000 226 230
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000 American Psychiatric Press Washington, DC
3. B.A. Baldo, K. Jain, L. Veraldi, G.F. Koob, and A. Markou A dopamine D1 agonist elevates self-stimulation thresholds: comparison to other dopamine-selective drugs Pharmacol. Biochem. Behav. 62 1999 659 672
4. M.T. Bardo, T.A. Green, P.A. Crooks, and L.P. Dwoskin Nornicotine is self-administered intravenously by rats Psychopharmacology (Berlin) 146 1999 290 296
5. 125I]iodosulpride Neuroscience 20 1987 117 155
6. A.W. Bruijnzeel, M.S. Gold, The role of corticotropin-releasing factor-like peptides in cannabis, nicotine and alcohol dependence, Brain Res. Rev. in press: Available online 25 February 2005.
7. A.W. Bruijnzeel, and A. Markou Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats Neuropharmacology 47 2004 572 579
8. A.W. Bruijnzeel, M. Repetto, and M.S. Gold Neurobiological mechanisms in addictive and psychiatric disorders Psychiatry Clin. North Am. 27 2004 661 674
9. D.L. Cameron, and J.T. Williams Dopamine D1 receptors facilitate transmitter release Nature 366 1993 344 347
10. W.A. Carlezon Jr., C.N. Haile, R. Coppersmith, Y. Hayashi, R. Malinow, R.L. Neve, and E.J. Nestler Distinct sites of opiate reward and aversion within the midbrain identified using a herpes simplex virus vector expressing GluR1 J. Neurosci. 20 2000 RC62
11. W.A. Corrigall, and K.M. Coen Selective dopamine antagonists reduce nicotine self-administration Psychopharmacology (Berlin) 104 1991 171 176
12. W.A. Corrigall, K.B. Franklin, K.M. Coen, and P.B. Clarke The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine Psychopharmacology (Berlin) 107 1992 285 289
13. P.A. Crooks, and L.P. Dwoskin Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking Biochem. Pharmacol. 54 1997 743 753
14. A. Dagher, C. Bleicher, J.A. Aston, R.N. Gunn, P.B. Clarke, and P. Cumming Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers Synapse 42 2001 48 53
15. K.M. Dewar, P.P. Rompre, J. Stewart, and R.A. Warren Excitotoxic lesions of the prefrontal cortex reduce dopamine D1-like receptors in the ventral tegmental area Eur. J. Pharmacol. 336 1997 155 158
16. M.P. Epping-Jordan, S.S. Watkins, G.F. Koob, and A. Markou Dramatic decreases in brain reward function during nicotine withdrawal Nature 393 1998 76 79
17. Y. Fu, S.G. Matta, W. Gao, V.G. Brower, and B.M. Sharp Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-d-aspartate receptors in the ventral tegmental area J. Pharmacol. Exp. Ther. 294 2000 458 465
18. P.A. Garris, M. Kilpatrick, M.A. Bunin, D. Michael, Q.D. Walker, and R.M. Wightman Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation Nature 398 1999 67 69
19. A.A. Harrison, F. Gasparini, and A. Markou Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats Psychopharmacology (Berlin) 160 2002 56 66
20. L. Hernandez, and B.G. Hoebel Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis Life Sci. 42 1988 1705 1712
21. Q. Huang, D. Zhou, K. Chase, J.F. Gusella, N. Aronin, and M. DiFiglia Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus Proc. Natl. Acad. Sci. U. S. A. 89 1992 11988 11992
22. G.E. Hunt, D.M. Atrens, and D.M. Jackson Reward summation and the effects of dopamine D1 and D2 agonists and antagonists on fixed-interval responding for brain stimulation Pharmacol. Biochem. Behav. 48 1994 853 862
23. S. Ikemoto The supramammillary nucleus mediates primary reinforcement via GABA(A) receptors Neuropsychopharmacology 30 2005 1088 1095
24. S. Ikemoto, D.B. Horton, and I.R. Macumber Self-administration of nicotine into the ventral tegmental area and adjacent regions Abstract Viewer and Itinerary Planner 2004 Society for Neuroscience Washington, DC Program No. 575.11. online
25. S. Ikemoto, B.M. Witkin, A. Zangen, and R.A. Wise Rewarding effects of AMPA administration into the supramammillary or posterior hypothalamic nuclei but not the ventral tegmental area J. Neurosci. 24 2004 5758 5765
26. S. Ivanova, and A.J. Greenshaw Nicotine-induced decreases in VTA electrical self-stimulation thresholds: blockade by haloperidol and mecamylamine but not scopolamine or ondansetron Psychopharmacology (Berlin) 134 1997 187 192
27. S.W. Johnson, and R.A. North Two types of neurone in the rat ventral tegmental area and their synaptic inputs J. Physiol. 450 1992 455 468
28. P.W. Kalivas, and P. Duffy D1 receptors modulate glutamate transmission in the ventral tegmental area J. Neurosci. 15 1995 5379 5388
29. P.J. Kenny, and A. Markou Neurobiology of the nicotine withdrawal syndrome Pharmacol. Biochem. Behav. 70 2001 531 549
30. P.J. Kenny, F. Gasparini, and A. Markou Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats J. Pharmacol. Exp. Ther. 306 2003 1068 1076
31. L. Kokkinidis, and B.D. McCarter Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects Pharmacol. Biochem. Behav. 36 1990 463 471
32. G.F. Koob, S.B. Caine, L. Parsons, A. Markou, and F. Weiss Opponent process model and psychostimulant addiction Pharmacol. Biochem. Behav. 57 1997 513 521
33. C. Kornetsky, and R.U. Esposito Euphorigenic drugs: effects on the reward pathways of the brain Fed. Proc. 38 1979 2473 2476
34. S.R. Laviolette, and K.D. van der The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour Nat. Rev., Neurosci. 5 2004 55 65
35. A.I. Levey, S.M. Hersch, D.B. Rye, R.K. Sunahara, H.B. Niznik, C.A. Kitt, D.L. Price, R. Maggio, M.R. Brann, and B.J. Ciliax Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies Proc. Natl. Acad. Sci. U. S. A. 90 1993 8861 8865
36. D. Lin, G.F. Koob, and A. Markou Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat-interactions between the two drugs Psychopharmacology (Berlin) 145 1999 283 294
37. X.Y. Lu, L. Churchill, and P.W. Kalivas Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area Synapse 25 1997 205 214
38. H.D. Mansvelder, and D.S. McGehee Long-term potentiation of excitatory inputs to brain reward areas by nicotine Neuron 27 2000 349 357
39. A. Markou, and G.F. Koob Postcocaine anhedonia. An animal model of cocaine withdrawal Neuropsychopharmacology 4 1991 17 26
40. A. Markou, and G.F. Koob Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations Physiol. Behav. 51 1992 111 119
41. A. Markou, T.R. Kosten, and G.F. Koob Neurobiological similarities in depression and drug dependence: a self-medication hypothesis Neuropsychopharmacology 18 1998 135 174
42. E. Miliaressis, C. Emond, and Z. Merali Re-evaluation of the role of dopamine in intracranial self-stimulation using in vivo microdialysis Behav. Brain Res. 46 1991 43 48
43. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Dopamine receptors: from structure to function Physiol. Rev. 78 1998 189 225
44. D. Nakahara, N. Ozaki, Y. Miura, H. Miura, and T. Nagatsu Increased dopamine and serotonin metabolism in rat nucleus accumbens produced by intracranial self-stimulation of medial forebrain bundle as measured by in vivo microdialysis Brain Res. 495 1989 178 181
45. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1998 Academic Press San Diego
46. S. Rahman, J. Zhang, and W.A. Corrigall Effects of acute and chronic nicotine on somatodendritic dopamine release of the rat ventral tegmental area: in vivo microdialysis study Neurosci. Lett. 348 2003 61 64
47. R. Ranaldi, and R.J. Beninger The effects of systemic and intracerebral injections of D1 and D2 agonists on brain stimulation reward Brain Res. 651 1994 283 292
48. R. Ranaldi, and R.A. Wise Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine J. Neurosci. 21 2001 5841 5846
49. A. Rezayof, M.R. Zarrindast, H. Sahraei, and A.H. Haeri-Rohani Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat Pharmacol. Biochem. Behav. 74 2002 187 197
50. P.P. Rompre, and P. Bauco GBR 12909 reverses the SCH 23390 inhibition of rewarding effects of brain stimulation Eur. J. Pharmacol. 182 1990 181 184
51. 3H]SCH 23390 Brain Res. 375 1986 291 301
52. B. Schilstrom, M.V. Fagerquist, X. Zhang, P. Hertel, G. Panagis, G.G. Nomikos, and T.H. Svensson Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area Synapse 38 2000 375 383
53. G. Schulteis, A. Markou, L.H. Gold, L. Stinus, and G.F. Koob Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis J. Pharmacol. Exp. Ther. 271 1994 1391 1398
54. G. Schulteis, A. Markou, M. Cole, and G.F. Koob Decreased brain reward produced by ethanol withdrawal Proc. Natl. Acad. Sci. U. S. A. 92 1995 5880 5884
55. W. Schultz Getting formal with dopamine and reward Neuron 36 2002 241 263
56. D.W. Self Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system Neuropharmacology 47 Suppl. 1 2004 242 255
57. R. Sharf, D.Y. Lee, and R. Ranaldi Microinjections of SCH 23390 in the ventral tegmental area reduce operant responding under a progressive ratio schedule of food reinforcement in rats Brain Res. 1033 2005 179 185
58. D.R. Sibley, and K.A. Neve Regulation of dopamine receptor function and expression K.A. Neve R.L. Neve The Dopamine Receptors 1997 Humana Press Totowa, NJ 383 424
59. J. Singh, T. Desiraju, and T.R. Raju Dopamine receptor sub-types involvement in nucleus accumbens and ventral tegmentum but not in medial prefrontal cortex: on self-stimulation of lateral hypothalamus and ventral mesencephalon Behav. Brain Res. 86 1997 171 179
60. K.L. Skjei, and A. Markou Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats Psychopharmacology (Berlin) 168 2003 280 292
61. C. Spielewoy, and A. Markou Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function Neuropsychopharmacology 28 2003 1106 1116
62. J.R. Stellar, and D. Corbett Regional neuroleptic microinjections indicate a role for nucleus accumbens in lateral hypothalamic self-stimulation reward Brain Res. 477 1989 126 143
63. J.R. Stellar, A.E. Kelley, and D. Corbett Effects of peripheral and central dopamine blockade on lateral hypothalamic self-stimulation: evidence for both reward and motor deficits Pharmacol. Biochem. Behav. 18 1983 433 442
64. I.P. Stolerman, and M.J. Jarvis The scientific case that nicotine is addictive Psychopharmacology (Berlin) 117 1995 2 10
65. S.S. Watkins, L. Stinus, G.F. Koob, and A. Markou Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects J. Pharmacol. Exp. Ther. 292 2000 1053 1064
66. N.M. White, M.G. Packard, and N. Hiroi Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens Psychopharmacology (Berlin) 103 1991 271 276
67. R.A. Wise Brain reward circuitry: insights from unsensed incentives Neuron 36 2002 229 240
68. R.A. Wise Dopamine, learning and motivation Nat. Rev., Neurosci. 5 2004 483 494
69. R.A. Wise, and E. Munn Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds Psychopharmacology (Berlin) 117 1995 130 136
70. Z.B. You, Y.Q. Chen, and R.A. Wise Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation Neuroscience 107 2001 629 639